Sign In
Sign In
This isn’t just a blip on the the radar, or a dastardly plot by the pharma industry to increase profits; it’s an evolution of how drugs are used to treat patients. (Photo: Shutterstock)
Recommended Stories
Health system consolidation: Can employer groups, brokers survive it?
Evidence suggests that consolidation among health systems leads to higher prices for services and stable or lower quality of care.
Medicare buy-in would cut billions in hospital revenues
A public option supported by an increasing number of Democrats is meeting pushback from hospital groups.
3 ways to position your small business benefits offering for success in 2019
How can small businesses position their companies for success and entice new workers into the fold?
Resource Center
eBook
Sponsored by Extensis Group
Guide to Employment Law: Topics Employers Must Know to Stay Compliant
Your clients may not know all the new rules and regulations they need to follow when it comes to their employees. Here’s a tool that can help.
White Paper
Sponsored by ArmadaCare
Targeted Benefit Boosting Solutions: Why Offering Carve-Out Coverage Remains a Viable Option
Help clients solve business problems with carve-out supplemental expense reimbursed insurance. What was once only referred to as “executive medical reimbursement” is still possible today, as long as it is structured correctly.
Guide
Sponsored by Assurity Life Insurance Company
Why Voluntary Benefits Mean More Than You Think
Help clients understand three reasons why voluntary benefits are no longer optional.
BenefitsPRO
Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!
- Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
- Exclusive discounts on BenefitsPRO.com and ALM events.
Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.